These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 3554628

  • 1. Observed differences in amikacin pharmacokinetic parameters and dosage recommendations determined by enzyme immunoassay and fluorescence polarization immunoassay.
    Bleske BE, Larson TA, Rotschafer JC.
    Ther Drug Monit; 1987; 9(1):48-52. PubMed ID: 3554628
    [Abstract] [Full Text] [Related]

  • 2. Observed differences in gentamicin pharmacokinetic parameters and dosage recommendations determined by fluorescent polarization immunoassay and radioimmunoassay methods.
    Rotschafer JC, Berg HG, Nelson RB, Strand L, Lakatua DJ.
    Ther Drug Monit; 1983; 5(4):443-7. PubMed ID: 6362098
    [Abstract] [Full Text] [Related]

  • 3. Comparison of gentamicin pharmacokinetic parameters determined by fluorescence polarization immunoassay and latex agglutination methods.
    Madaras-Kelly KJ, Mihalovic S, Zittel D, Ehresman D, Lakatua DJ, Rotschafer JC.
    Ther Drug Monit; 1994 Aug; 16(4):395-9. PubMed ID: 7974630
    [Abstract] [Full Text] [Related]

  • 4. Comparison of radioimmunoassay and enzyme immunoassay methods in determining gentamicin pharmacokinetic parameters and dosages.
    Rotschafer JC, Morlock C, Strand L, Crossley K.
    Antimicrob Agents Chemother; 1982 Oct; 22(4):648-51. PubMed ID: 6758688
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH, Rong XZ, Hua R, Zhang T.
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [Abstract] [Full Text] [Related]

  • 6. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay methods in a theophylline pharmacokinetic study.
    Lalonde RL, Bottorff MB, Straughn AB.
    Ther Drug Monit; 1985 Feb; 7(4):442-6. PubMed ID: 3909536
    [Abstract] [Full Text] [Related]

  • 7. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics.
    Bottorff MB, Lalonde RL, Straughn AB.
    Biopharm Drug Dispos; 1987 Feb; 8(3):213-21. PubMed ID: 3297181
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.
    Lacarelle B, Granthil C, Manelli JC, Bruder N, Francois G, Cano JP.
    Ther Drug Monit; 1987 Jun; 9(2):154-60. PubMed ID: 3617153
    [Abstract] [Full Text] [Related]

  • 9. Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx and dry chemistry enzyme immunoassay on the Vitros 950.
    Solnica B.
    Clin Chem Lab Med; 2004 Jun; 42(8):958-64. PubMed ID: 15387450
    [Abstract] [Full Text] [Related]

  • 10. A population approach to the forecasting of amikacin plasma and urinary levels using a prescribed dosage regimen.
    Joubert P, Bressolle F, Gouby A, Douçot PY, Saissi G, Gomeni R.
    Eur J Drug Metab Pharmacokinet; 1999 Jun; 24(1):39-46. PubMed ID: 10412890
    [Abstract] [Full Text] [Related]

  • 11. [Use of fluorescence polarization immunoassay and microbiological assay in the study of gentamicin pharmacokinetics in man and a comparison of the results].
    Cai WM, Chen G.
    Yao Xue Xue Bao; 1990 Jun; 25(2):81-4. PubMed ID: 2239326
    [Abstract] [Full Text] [Related]

  • 12. [Determining the methotrexate concentration in serum with the fluorescence polarization immunoassay (FPIA)--a comparison with the enzyme immunoassay (EMIT)].
    Liappis N.
    Klin Padiatr; 1986 Jun; 198(1):33-6. PubMed ID: 3515034
    [Abstract] [Full Text] [Related]

  • 13. Long-wavelength fluorescence polarization immunoassay: determination of amikacin on solid surface and gliadins in solution.
    Sánchez-Martínez ML, Aguilar-Caballos MP, Gómez-Hens A.
    Anal Chem; 2007 Oct 01; 79(19):7424-30. PubMed ID: 17784730
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients.
    Canis F, Husson MO, Turck D, Vic P, Launay V, Ategbo S, Vincent A, Courcol RJ.
    J Antimicrob Chemother; 1997 Mar 01; 39(3):431-3. PubMed ID: 9096197
    [Abstract] [Full Text] [Related]

  • 15. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
    Mendu DR, Chou PP, Soldin SJ.
    Ther Drug Monit; 2007 Oct 01; 29(5):632-7. PubMed ID: 17898655
    [Abstract] [Full Text] [Related]

  • 16. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM, Dominguez-Gil A, Tabernero JM, Molina HD.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 01; 20(6):271-5. PubMed ID: 7107075
    [Abstract] [Full Text] [Related]

  • 17. Performance of a fluorescence polarization immunoassay system evaluated by therapeutic monitoring of four drugs.
    Zaninotto M, Secchiero S, Paleari CD, Burlina A.
    Ther Drug Monit; 1992 Aug 01; 14(4):301-5. PubMed ID: 1519304
    [Abstract] [Full Text] [Related]

  • 18. Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays.
    Miles MV, Howlett CM, Tennison MB, Greenwood RS, Cross RE.
    Ther Drug Monit; 1989 Aug 01; 11(3):337-42. PubMed ID: 2658212
    [Abstract] [Full Text] [Related]

  • 19. Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.
    Garraffo R, Iliadis A, Cano JP, Dellamonica P, Lapalus P.
    J Pharm Sci; 1989 Sep 01; 78(9):753-7. PubMed ID: 2585270
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
    White LO, Holt HA, Reeves DS, MacGowan AP.
    J Antimicrob Chemother; 1997 Mar 01; 39(3):355-61. PubMed ID: 9096185
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.